Medical Devices France

France Autoimmune Disease Diagnostics Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

France Autoimmune Disease Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Product, Disease, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

France · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $136.5 Mn Placeholder estimate
Estimate 2025 $143.7 Mn 2.3% of the global market
Projected 2034 $226.7 Mn 57.8% Adds $83.0 Mn over 9 forecast years
CAGR 2025–2034 5.2% Faster than 18% of 193 Medical Devices markets here
Key players 6 +1
  • France is 2.32% of the global market.
  • In Europe, the largest is Germany at $208.2 Mn.
  • Fastest growing: Russia at 6.1% a year.
  • France ranks 4th of 13 by size in Europe.

Market size projection

France

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$83.0 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Autoimmune Disease Diagnostics Market market size by year, France
YearMarket sizeChange that yearSince 2025
2024 (estimate) $136.5 Mn — —
2025 (base) $143.7 Mn +$7.1 Mn —
2026 (forecast) $151.1 Mn +$7.5 Mn +5.2%
2027 (forecast) $159.0 Mn +$7.9 Mn +10.7%
2028 (forecast) $167.2 Mn +$8.3 Mn +16.4%
2029 (forecast) $175.9 Mn +$8.7 Mn +22.5%
2030 (forecast) $185.1 Mn +$9.1 Mn +28.8%
2031 (forecast) $194.7 Mn +$9.6 Mn +35.5%
2032 (forecast) $204.8 Mn +$10.1 Mn +42.6%
2033 (forecast) $215.5 Mn +$10.7 Mn +50%
2034 (forecast) $226.7 Mn +$11.2 Mn +57.8%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

France Autoimmune Disease Diagnostics Market Analysis at a glance
Market size, 2025$143.7 Mn placeholder estimate
Forecast, 2034$226.7 Mn placeholder estimate
Growth (CAGR), 2025–20345.2% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, disease and end user (see all)
Key playersThermo Fisher Scientific Inc., Bio-Rad Laboratories, Werfen, Siemens Healthineers, Euroimmun and 1 more (see all)
Regulator in FranceANSMSource: ANSM, French medicines agency. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The France Autoimmune Disease Diagnostics Market Analysis Executive Summary

Autoimmune disease diagnostics are blood tests that find antibodies and markers to diagnose and track diseases such as lupus and arthritis.

Key segments of the autoimmune disease diagnostics market include product (Immunoassay Kits, Analyzers and Reagents) and disease (Rheumatoid Arthritis, Lupus and Multiple Sclerosis).

Bar chart: France Autoimmune Disease Diagnostics market size, 2024–2034, placeholder estimates. $136.5 Mn in 2024, $143.7 Mn in 2025 and $226.7 Mn in 2034, 5.2% CAGR.
France Autoimmune Disease Diagnostics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

France Autoimmune Disease Diagnostics Market Dynamics

Market Growth Drivers

Falling costs of testing, more demand for precision medicine and steady research spending by drug makers and labs are driving the autoimmune disease diagnostics market.

Opportunity

Automation, smaller and cheaper instruments and growth in cancer and genetic testing give the autoimmune disease diagnostics market room to grow.

Market Restraints

Costly instruments, a shortage of skilled lab staff and uneven payment for new tests hold back the autoimmune disease diagnostics market.

Competitive Landscape for Autoimmune Disease Diagnostics Market in France

The autoimmune disease diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Autoimmune Disease Diagnostics Market in France

Autoimmune Disease Diagnostics in France: rules and payment

Medical devices need CE marking under the EU Medical Device Regulation (MDR); ANSM, the French medicines agency, monitors their safety in France.⁠[1] National health insurance (Assurance Maladie) pays back part of most care costs, and the HAS, the French National Authority for Health, advises on what it should cover.⁠[2]

[1] ANSM, French medicines agency. Checked 14 Nov 2026.

[2] Assurance Maladie (ameli.fr). Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how autoimmune disease diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in France.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Autoimmune Disease Diagnostics right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Autoimmune Disease Diagnostics in context

France compared

  • Health spending per person: 5,327 US$ per person (2024). World: 1,317 US$ per person (2023). 8th highest of the 13 countries we cover in Europe.[1]
  • Doctors: 3.28 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 12th highest of the 13 countries we cover in Europe.[2]
  • People aged 65 and over: 22.5% of people (2025). World: 10.4% of people (2025). 3rd highest of the 13 countries we cover in Europe.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 22 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 21 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Autoimmune Disease Diagnostics market in France?
Placeholder estimate: about $143.7 Mn in 2025, rising to about $226.7 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Autoimmune Disease Diagnostics market in France growing?
Placeholder estimate: about 5.2% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Autoimmune Disease Diagnostics market report cover?
The report splits the market by product (Immunoassay Kits, Analyzers, Reagents), disease (Rheumatoid Arthritis, Lupus, Multiple Sclerosis, Type 1 Diabetes and more) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Autoimmune Disease Diagnostics market?
Key players include Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Werfen, Siemens Healthineers, Euroimmun and Roche.
What is driving the Autoimmune Disease Diagnostics market?
Falling costs of testing, more demand for precision medicine and steady research spending by drug makers and labs are driving the autoimmune disease diagnostics market.
Who regulates Autoimmune Disease Diagnostics in France?
Medical devices need CE marking under the EU Medical Device Regulation (MDR); ANSM, the French medicines agency, monitors their safety in France. Source: ANSM, French medicines agency. Checked 14 Nov 2026.
How is healthcare paid for in France?
National health insurance (Assurance Maladie) pays back part of most care costs, and the HAS, the French National Authority for Health, advises on what it should cover. Source: Assurance Maladie (ameli.fr). Checked 14 Nov 2026.
Back to Catalogue

Related Medical Devices reports in France

See all

Related on autoimmune diseases and diagnostics and lab testing

See the topic